CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Adefovir dipivoxil

Last Updated: June 29, 2007
Result type: Reports
Project Number: SF0103-000
Product Line: Reimbursement Review

Generic Name: Adefovir dipivoxil

Brand Name: Hepsera

Manufacturer: gilead Sciences Canada Inc.

Therapeutic Area: Hepatitis B

Indications: Hepatitis B

Submission Type: Request For Advice

Project Status: Complete

Date Recommendation Issued: October 18, 2007

Recommendation Type: List with clinical criteria and/or conditions